T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.44T
| $29.8B | 4.19% |
314,745,120
-275,560
| -0.1% | -$25.7M |
|
2
Microsoft
MSFT
$2.9T
| $26B | 3.65% |
194,055,628
+194,702
| +0.1% | +$24.7M |
|
3
Meta Platforms (Facebook)
META
$1.49T
| $20.7B | 2.9% |
107,134,037
-812,533
| -0.8% | -$148M |
|
4
Visa
V
$677B
| $13.7B | 1.92% |
78,658,915
+379,577
| +0.5% | +$62.2M |
|
5
Boeing
BA
$169B
| $13B | 1.83% |
35,740,551
+2,607,364
| +8% | +$951M |
|
6
Alphabet (Google) Class C
GOOG
$4.11T
| $12.4B | 1.74% |
229,609,340
+13,498,480
| +6% | +$779M |
|
7
Alibaba
BABA
$276B
| $11.1B | 1.56% |
65,655,896
+5,932,300
| +10% | +$1.02B |
|
8
Becton Dickinson
BDX
$46.4B
| $8.63B | 1.21% |
35,107,007
+134,824
| +0.4% | +$31.3M |
|
9
Mastercard
MA
$498B
| $8.03B | 1.13% |
30,362,830
-498,108
| -2% | -$125M |
|
|
10
Alphabet (Google) Class A
GOOGL
$4.12T
| $7.5B | 1.05% |
138,564,160
-3,265,180
| -2% | -$189M |
|
|
11
UnitedHealth
UNH
$382B
| $6.88B | 0.97% |
28,209,162
-9,453,479
| -25% | -$2.27B |
|
12
Stryker
SYK
$135B
| $6.6B | 0.93% |
32,120,478
-901,635
| -3% | -$172M |
|
13
Intuit
INTU
$91.1B
| $5.83B | 0.82% |
22,293,230
-153,447
| -0.7% | -$39M |
|
14
Netflix
NFLX
$307B
| $5.78B | 0.81% |
157,481,860
+2,975,820
| +2% | +$107M |
|
15
Roper Technologies
ROP
$40.4B
| $5.61B | 0.79% |
15,309,455
-58,525
| -0.4% | -$20.8M |
|
16
Danaher
DHR
$138B
| $5.58B | 0.78% |
44,040,635
+1,186,587
| +3% | +$140M |
|
17
Intuitive Surgical
ISRG
$127B
| $5.36B | 0.75% |
30,666,069
-605,811
| -2% | -$104M |
|
18
Salesforce
CRM
$154B
| $5.15B | 0.72% |
33,910,865
+4,046,077
| +14% | +$634M |
|
19
Thermo Fisher Scientific
TMO
$214B
| $5.03B | 0.71% |
17,139,325
+395,830
| +2% | +$109M |
|
20
Apple
AAPL
$4.97T
| $4.82B | 0.68% |
97,464,744
-3,751,044
| -4% | -$183M |
|
21
Sempra
SRE
$58.1B
| $4.81B | 0.68% |
69,978,866
+7,638,344
| +12% | +$501M |
|
22
PayPal
PYPL
$49.9B
| $4.79B | 0.67% |
41,844,866
+1,361
| +0% | +$151K |
|
23
Elevance Health
ELV
$81.5B
| $4.79B | 0.67% |
16,956,198
-2,328,453
| -12% | -$636M |
|
|
24
Booking.com
BKNG
$156B
| $4.69B | 0.66% |
62,566,325
-15,629,725
| -20% | -$1.12B |
|
|
FISV
25
Fiserv Inc
FISV
$29.7B
| $4.66B | 0.65% |
51,136,590
+3,933,642
| +8% | +$345M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.